Literature DB >> 30031209

Neuroprotective effects of epoxyeicosatrienoic acids.

Lai Wang1, Gan Luo1, Long-Fei Zhang1, Hui-Xia Geng2.   

Abstract

Eicosatrienoic acids (EETs) are a class of intermediates produced during arachidonic acid metabolism mediated by cytochrome P450 epoxygenases that exert multiple physiological effects on the nervous system. EETs promote three metabolic processes, including esterification, hydrolysis and degradation or extension. EETs are hydrolyzed by soluble epoxide hydrolase (sEH) to form corresponding diols, thereby reducing their biological activity. Strategies regulating sEH expression or activity affect EET hydrolysis and alter relative cell concentrations, thus influencing EET function. This article summarizes the metabolic pathway of eicosatrienoic acid in organisms and highlights its neuroprotective effects on the central nervous system, which include regulating neuronal excitability, increasing cerebral blood flow, inhibiting neuronal apoptosis, reducing neuroinflammation, mitigating brain injury and promoting recovery of neurological function in subjects with nervous system diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; Cytochrome P450 epoxygenases; Eicosatrienoic acids; Nervous system; Neuroprotection

Mesh:

Substances:

Year:  2018        PMID: 30031209     DOI: 10.1016/j.prostaglandins.2018.07.002

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  9 in total

1.  Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.

Authors:  Yijun Shen; Weifeng Peng; Qinglan Chen; Bruce D Hammock; Junyan Liu; Dongyang Li; Jun Yang; Jing Ding; Xin Wang
Journal:  Brain Behav Immun       Date:  2019-07-12       Impact factor: 7.217

Review 2.  The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Authors:  Peter Solár; Alemeh Zamani; Klaudia Lakatosová; Marek Joukal
Journal:  Fluids Barriers CNS       Date:  2022-04-11

3.  Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.

Authors:  Christian Griñán-Ferré; Sandra Codony; Eugènia Pujol; Jun Yang; Rosana Leiva; Carmen Escolano; Dolors Puigoriol-Illamola; Júlia Companys-Alemany; Rubén Corpas; Coral Sanfeliu; Belen Pérez; M Isabel Loza; José Brea; Christophe Morisseau; Bruce D Hammock; Santiago Vázquez; Mercè Pallàs; Carles Galdeano
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 4.  Targeting arachidonic acid-related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles.

Authors:  Sherif M Shoieb; Mahmoud A El-Ghiaty; Ayman O S El-Kadi
Journal:  Emergent Mater       Date:  2020-11-17

5.  Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease.

Authors:  Christian Griñán-Ferré; Júlia Companys-Alemany; Júlia Jarné-Ferrer; Sandra Codony; Celia González-Castillo; Daniel Ortuño-Sahagún; Lluïsa Vilageliu; Daniel Grinberg; Santiago Vázquez; Mercè Pallàs
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

6.  Inhibition of Soluble Epoxide Hydrolase Is Protective against the Multiomic Effects of a High Glycemic Diet on Brain Microvascular Inflammation and Cognitive Dysfunction.

Authors:  Saivageethi Nuthikattu; Dragan Milenkovic; Jennifer E Norman; John Rutledge; Amparo Villablanca
Journal:  Nutrients       Date:  2021-11-01       Impact factor: 5.717

Review 7.  Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.

Authors:  Kabir Ahluwalia; Brandon Ebright; Kingsley Chow; Priyal Dave; Andrew Mead; Roy Poblete; Stan G Louie; Isaac Asante
Journal:  Metabolites       Date:  2022-04-07

8.  The Brain's Microvascular Response to High Glycemia and to the Inhibition of Soluble Epoxide Hydrolase Is Sexually Dimorphic.

Authors:  Saivageethi Nuthikattu; Dragan Milenkovic; Jennifer E Norman; John Rutledge; Amparo Villablanca
Journal:  Nutrients       Date:  2022-08-23       Impact factor: 6.706

Review 9.  The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.

Authors:  Sanjay K Nigam; Kevin T Bush; Vibha Bhatnagar; Samuel M Poloyac; Jeremiah D Momper
Journal:  Clin Pharmacol Ther       Date:  2020-04-11       Impact factor: 6.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.